Identification and functional analysis of miRNAs that are involved in carcinogenesis of a new molecular subgroup of colorectal cancer
| Project/Area Number |
25870048
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Gastroenterology
Tumor diagnostics
|
|---|
| Research Institution | Tohoku University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2013-04-01 – 2015-03-31
|
| Project Status |
Completed (Fiscal Year 2014)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2013: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
|
|---|
| Keywords | 大腸癌 / miRNA / BRAF / CIMP / MSI / 大腸がん発がん / BRAF遺伝子 / microRNA |
|---|
| Outline of Final Research Achievements |
The aim of this study was to identify specific miRNAs that could be involved in oncogenesis of a molecular subgroup, the MSI/CIMP/BRAF-mutant colorectal cancer, and clarify biological functions of the miRNAs. By using genome-wide miRNA expression analysis, we found some miRNAs specifically dysregulated in BRAF-mutant colorectal cancer, and identified a specific miRNA that acts as a tumor suppressor in colorectal cancer. We further revealed a correlation between the miRNA expression and therapeutic outcome of those who received anti-EGFR therapy. These results suggest that the miRNA contributes to oncogenic process of colorectal cancer, particularly BRAF-mutant cancer, and influences clinical outcome of patients with colorectal cancer. The results could lead to further developing novel targeted therapies of colorectal cancer.
|
Report
(3 results)
Research Products
(2 results)
